Tuberculosis drug resistance in Europe: sunny days, but clouds on the horizon?

Schluger N. W.

Source: Eur Respir J 2007; 30: 825-827
Journal Issue: November
Disease area: Respiratory infections

Full text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Schluger N. W.. Tuberculosis drug resistance in Europe: sunny days, but clouds on the horizon?. Eur Respir J 2007; 30: 825-827

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.

Related content which might interest you:
Clean air in Europe: beyond the horizon?
Source: Eur Respir J 2015; 45: 7-10
Year: 2015

The air of Europe: where are we going?
Source: Eur Respir Rev, 26 (146) 170024; 10.1183/16000617.0024-2017
Year: 2017

Introduction: The burden of tuberculosis drug resistance in Eastern Europe: the Moldavian experience
Source: Annual Congress 2010 - Multidrug-resistant and extensively drug-resistant tuberculosis
Year: 2010

Tuberculosis situation and control in Europe: where are we and what to do next?
Source: Eur Respir J 2005; 26: Suppl. 49, 476s
Year: 2005

Dynamics analysis of MBT drug resistance to antitubercolosis second-line drugs (Saratov region hospital, Russia)
Source: International Congress 2016 – Update on drug-resistant tuberculosis
Year: 2016

Trend of acquired drug resistance to main anti TB drugs in the first 7 years of applying DOT strategy in Iasi County, Romania
Source: Annual Congress 2007 - Tuberculosis control
Year: 2007

Dynamics of MBT drug resistance in Saratov Region Hospital, Russia
Source: International Congress 2016 – Epidemiological insights into tuberculosis pathogenesis
Year: 2016

Tuberculosis in Germany: a declining trend coming to an end?
Source: Eur Respir J 2016; 47: 667-670
Year: 2016

Seasonality of tuberculosis in an Eastern-Asian country with an extreme continental climate
Source: Eur Respir J 2009; 34: 921-925
Year: 2009

Dynamics of primary multidrug drug resistance in Novokuznetsk over 10 years period
Source: International Congress 2016 – New insights into aspects of tuberculosis epidemiology
Year: 2016

Impact of African immigration on drug resistance to mycobacterium tuberculosis in Portugal
Source: Annual Congress 2011 - Tuberculosis in special populations
Year: 2011

Tuberculosis elimination in Oman: winning the war on the disease
Source: ERJ Open Res, 4 (4) 00121-2018; 10.1183/23120541.00121-2018
Year: 2018

TB elimination: a dream or a reality? Key lessons from the ERS external course in Dubrovnik, Croatia
Source: Breathe 2013; 9: 458-461
Year: 2013

XDR-TB in South Africa: from clinical management to public-health action
Source: Annual Congress 2011 - PG12 TB-PAN-NET Multidrug-resistant and extensively drug-resistant tuberculosis: update on clinical management
Year: 2011

Trend and risk factors of drug resistance tuberculosis between 2005-2012 in Istanbul, Turkey
Source: International Congress 2015 – Management of TB: a patient focus
Year: 2015

Anti-tuberculosis drug resistance distinctive features -The Republic of Azerbaijan 2012-2013
Source: International Congress 2015 – Management of TB: a patient focus
Year: 2015